Get the Stockscreener App
0.00
100.00%
-9.60
Optinose Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
See More
Previous Close:
$9.60
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$98.13M
Revenue:
$75.67M
Net Income/Loss:
$-31.15M
P/E Ratio:
0.00
EPS:
-0.2777
Net Cash Flow:
$-39.79M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$17.25
Optinose Inc Stock (OPTN) Company Profile
Name
Optinose Inc
Sector
Phone
267-364-3500
Address
777 TOWNSHIP LINE ROAD, YARDLEY, PA
Compare OPTN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
0.00 | 98.13M | 75.67M | -31.15M | -39.79M | -0.2777 |
|
ZTS
Zoetis Inc
|
151.54 | 70.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 47.44B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.69 | 45.15B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.01 | 19.07B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.42 | 13.28B | 2.99B | 1.21B | 1.13B | 25.06 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-25 | Downgrade | Lake Street | Buy → Hold |
| Jan-03-25 | Reiterated | H.C. Wainwright | Buy |
| Mar-11-24 | Initiated | H.C. Wainwright | Buy |
| Aug-21-23 | Initiated | Lake Street | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Dec-18-19 | Initiated | Cowen | Outperform |
| Aug-08-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Optinose Inc Stock (OPTN) Latest News
What makes OptiNose Inc. stock price move sharplyPrecision Entry Strategy - Newser
How OptiNose Inc. stock performs during market volatilitySmart Return Focused Trading - Newser
Why OptiNose Inc. stock attracts strong analyst attentionProven High Yield Signals - Newser
Millennium Management LLC Sells 616,267 Shares of OptiNose, Inc. (NASDAQ:OPTN) - Defense World
FMR LLC Reduces Holdings in OptiNose Inc by 86.79% - GuruFocus
OptiNose, Inc. (NASDAQ:OPTN) Shares Sold by Jane Street Group LLC - Defense World
Northern Trust Corp Has $94,000 Stake in OptiNose, Inc. (NASDAQ:OPTN) - Defense World
(OPTN) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Optinose CEO and other top executives exit after company's acquisition by Paratek - The Business Journals
OptiNose, Inc.(NasdaqGS: OPTN) dropped from S&P Global BMI Index - marketscreener.com
OptiNose, Inc.(NasdaqGS: OPTN) dropped from S&P TMI Index - marketscreener.com
Akin Advised Pharmakon in its Debt Financing for Optinose’s Sale to Paratek Pharmaceuticals - Akin Gump Strauss Hauer & Feld LLP
Paratek expands commercial portfolio with Optinose - Yahoo Finance
BioPharma Credit Receives $83 Million from OptiNose Sale - marketscreener.com
Q2 Earnings Estimate for OptiNose Issued By HC Wainwright - Defense World
Paratek Pharmaceuticals Completes Acquisition of Optinose (OPTN) - GuruFocus
Optinose Acquired by Paratek Pharmaceuticals for $330 Million - TipRanks
Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies - The Manila Times
Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies - Benzinga
OptiNose, Inc. (NASDAQ:OPTN) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
OptiNose (NASDAQ:OPTN) Receives “Neutral” Rating from HC Wainwright - Defense World
OptiNose (OPTN) Maintains Neutral Rating and Price Target at $9 | OPTN Stock News - GuruFocus
(OPTN) Proactive Strategies - news.stocktradersdaily.com
OptiNose Shareholders Approve Merger with Paratek By Investing.com - Investing.com Nigeria
Optinose Stockholders Approve Merger with Paratek - TipRanks
OptiNose Shareholders Approve Merger with Paratek - Investing.com
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
OptiNose Inc reports results for the quarter ended March 31Earnings Summary - TradingView
OptiNose: Q1 Earnings Snapshot - MySA
OptiNose (OPTN) to Release Earnings on Tuesday - Defense World
OptiNose Inc expected to post a loss of 74 cents a shareEarnings Preview - TradingView
Trend Tracker for (OPTN) - news.stocktradersdaily.com
OptiNose, Inc. (NASDAQ:OPTN) Shares Sold by Renaissance Technologies LLC - Defense World
Geode Capital Management LLC Has $576,000 Stake in OptiNose, Inc. (NASDAQ:OPTN) - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc.OPTN - Business Wire
Press Release Distribution & PR Platform - ACCESS Newswire
Trading (OPTN) With Integrated Risk Controls - news.stocktradersdaily.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: The AZEK Company Inc. (NYSEAZEK), Mesa Air Group, Inc. (NasdaqMESA), Mr. Cooper Group Inc. (Nasdaq – COOP), Optinose, Inc. (NasdaqOPTN) - Morningstar
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
After Fielding Multiple Offers, Yardley-Based Optinose Secures Potential $330M Deal With Paratek - BUCKSCO.Today
How a Bucks County firm's multiyear pursuit of a partner led to a potential $330M deal - The Business Journals
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COOP, MESA on Behalf of Shareholders - The Malaysian Reserve
Optinose Inc Stock (OPTN) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.43%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):